First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.

First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.
Russia’s Sputnik V coronavirus vaccine gives around 92% protection against COVID-19, results published in The Lancet reveal.
A new simulator can accurately model COVID-19 and the effects of different mitigation strategies, which researchers say could help guide new policies to combat the pandemic.
Whilst vaccines against COVID-19 show there is light at the end of the tunnel, three main challenges still need to be addressed.
The testing platform identifies the presence of two antibodies in microliter samples of blood.
The results of the company’s COVID-19 vaccine clinical trials are the first to be published in a peer-reviewed journal.
US company second to report impressive efficacy for its COVID-19 vaccine candidate.
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
An inventive new approach lowers the limit of detection for a common assay, allowing researchers to identify elusive biomarkers in complex fluids, like the blood.
Measures that could have been taken at the beginning of the pandemic were not implemented as precautionary preparation but rather as reactionary to an already spreading virus, making it hard to contain.